While a modest regain, this stands in stark contrast to the substantial weight gain observed in the placebo group, demonstrating the efficacy of orforglipron in maintaining the majority of treatment-induced weight loss
Cruciferous vegetable supplementation in a controlled diet study alters the serum peptidome in a GSTM1-genotype dependent manner
Studies have shown that GLP-1 receptor agonists can improve menstrual regularity and increase ovulation rates
In total, 61 liver cirrhosis patients were randomly assigned to placebo, vitamin B-6 (50 mg pyridoxine/d), GSH (500 mg/d), or B-6 + GSH groups for 12 weeks
Retatrutide and survodutide have produced or are generating diabetes-related trial data, but neither is approved for diabetes
Hair loss medically referred to as telogen effluvium when associated with physiological stress or rapid weight change has not been formally listed as a confirmed adverse effect of retatrutide in published trial data